Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Alcon downgraded to Sell from Neutral at Citi » 06:24
07/06/20
07/06
06:24
07/06/20
06:24
ALC

Alcon

$58.76 /

+0.32 (+0.55%)

Citi analyst Joanne…

Citi analyst Joanne Wuensch downgraded Alcon to Sell from Neutral with an unchanged price target of $55. With COVID-19, Alcon "bore the brunt" of not only lower surgical sales as cataract surgery came to a near standstill in the beginning of Q2, but also vision care sales with fewer patient visits in the ophthalmologist office, Wuensch tells investors in a research note. The analyst believes a potential recovery is now fully valued into Alcon shares.

ShowHide Related Items >><<
ALC Alcon
$58.76 /

+0.32 (+0.55%)

ALC Alcon
$58.76 /

+0.32 (+0.55%)

06/16/20 Guggenheim
Guggenheim upgrades Alcon to Buy on strong momentum exiting shutdown
06/16/20 Guggenheim
Alcon upgraded to Buy from Neutral at Guggenheim
06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/21/20 JPMorgan
Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan
ALC Alcon
$58.76 /

+0.32 (+0.55%)

Over a week ago
Conference/Events
Alcon management to meet with Morgan Stanley » 09:25
06/23/20
06/23
09:25
06/23/20
09:25
ALC

Alcon

$60.76 /

-0.19 (-0.31%)

Medical Technology…

Medical Technology Analyst Lewis holds a conference call with CEO Endicott on June 23 at 10 am hosted by Morgan Stanley.

ShowHide Related Items >><<
ALC Alcon
$60.76 /

-0.19 (-0.31%)

ALC Alcon
$60.76 /

-0.19 (-0.31%)

06/16/20 Guggenheim
Guggenheim upgrades Alcon to Buy on strong momentum exiting shutdown
06/16/20 Guggenheim
Alcon upgraded to Buy from Neutral at Guggenheim
06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/21/20 JPMorgan
Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan
ALC Alcon
$60.76 /

-0.19 (-0.31%)

Conference/Events
Alcon management to meet with Morgan Stanley » 04:55
06/23/20
06/23
04:55
06/23/20
04:55
ALC

Alcon

$60.76 /

-0.19 (-0.31%)

Medical Technology…

Medical Technology Analyst Lewis holds a conference call with CEO Endicott on June 23 at 10 am hosted by Morgan Stanley.

ShowHide Related Items >><<
ALC Alcon
$60.76 /

-0.19 (-0.31%)

ALC Alcon
$60.76 /

-0.19 (-0.31%)

06/16/20 Guggenheim
Guggenheim upgrades Alcon to Buy on strong momentum exiting shutdown
06/16/20 Guggenheim
Alcon upgraded to Buy from Neutral at Guggenheim
06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/21/20 JPMorgan
Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan
ALC Alcon
$60.76 /

-0.19 (-0.31%)

Conference/Events
Alcon management to meet with Morgan Stanley » 16:25
06/22/20
06/22
16:25
06/22/20
16:25
ALC

Alcon

$60.76 /

-0.19 (-0.31%)

Medical Technology…

Medical Technology Analyst Lewis holds a conference call with CEO Endicott on June 23 at 10 am hosted by Morgan Stanley.

ShowHide Related Items >><<
ALC Alcon
$60.76 /

-0.19 (-0.31%)

ALC Alcon
$60.76 /

-0.19 (-0.31%)

06/16/20 Guggenheim
Guggenheim upgrades Alcon to Buy on strong momentum exiting shutdown
06/16/20 Guggenheim
Alcon upgraded to Buy from Neutral at Guggenheim
06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/21/20 JPMorgan
Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan
ALC Alcon
$60.76 /

-0.19 (-0.31%)

Upgrade
Guggenheim upgrades Alcon to Buy on strong momentum exiting shutdown » 07:08
06/16/20
06/16
07:08
06/16/20
07:08
ALC

Alcon

$57.97 /

+0.385 (+0.67%)

, NVS

Novartis

$85.17 /

+0.81 (+0.96%)

As previously reported,…

As previously reported, Guggenheim analyst Chris Pasquale upgraded Alcon (ALC) to Buy from Neutral with a $68 price target. Over the last 14 months, since Alcon's spinoff from Novartis (NVS), the stock's premium has "nearly been cut in half," but his own optimism about the company's long-term growth potential has not changed, Pasquale tells investors. He sees strong momentum in its key segments, is encouraged by early signs of a rebound in eye care volumes, and contends consensus estimates for 2021 "have overshot to the downside," the analyst added.

ShowHide Related Items >><<
NVS Novartis
$85.17 /

+0.81 (+0.96%)

ALC Alcon
$57.97 /

+0.385 (+0.67%)

ALC Alcon
$57.97 /

+0.385 (+0.67%)

06/16/20 Guggenheim
Alcon upgraded to Buy from Neutral at Guggenheim
06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/21/20 JPMorgan
Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan
05/14/20 UBS
Alcon price target raised to CHF 65 from CHF 60 at UBS
NVS Novartis
$85.17 /

+0.81 (+0.96%)

06/15/20
Fly Intel: Top five analyst upgrades
06/15/20 Citi
Novartis upgraded to Buy from Neutral at Citi
06/03/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Genmab, says ofatumumab delay not impactful
05/18/20 Jefferies
Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas
NVS Novartis
$85.17 /

+0.81 (+0.96%)

ALC Alcon
$57.97 /

+0.385 (+0.67%)

NVS Novartis
$85.17 /

+0.81 (+0.96%)

NVS Novartis
$85.17 /

+0.81 (+0.96%)

NVS Novartis
$85.17 /

+0.81 (+0.96%)

Upgrade
Alcon upgraded to Buy from Neutral at Guggenheim » 06:06
06/16/20
06/16
06:06
06/16/20
06:06
ALC

Alcon

$57.97 /

+0.385 (+0.67%)

Guggenheim upgraded Alcon…

Guggenheim upgraded Alcon to Buy from Neutral.

ShowHide Related Items >><<
ALC Alcon
$57.97 /

+0.385 (+0.67%)

ALC Alcon
$57.97 /

+0.385 (+0.67%)

06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/21/20 JPMorgan
Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan
05/14/20 UBS
Alcon price target raised to CHF 65 from CHF 60 at UBS
05/14/20 Stephens
Alcon upgraded to Overweight on quicker bounce back potential at Stephens
ALC Alcon
$57.97 /

+0.385 (+0.67%)

Conference/Events
Alcon management to meet virtually with BTIG » 04:55
06/15/20
06/15
04:55
06/15/20
04:55
ALC

Alcon

$57.58 /

-0.4 (-0.69%)

Virtual Meeting to be…

Virtual Meeting to be held on June 15 hosted by BTIG.

ShowHide Related Items >><<
ALC Alcon
$57.58 /

-0.4 (-0.69%)

ALC Alcon
$57.58 /

-0.4 (-0.69%)

06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/21/20 JPMorgan
Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan
05/14/20 UBS
Alcon price target raised to CHF 65 from CHF 60 at UBS
05/14/20 Stephens
Alcon upgraded to Overweight on quicker bounce back potential at Stephens
ALC Alcon
$57.58 /

-0.4 (-0.69%)

Conference/Events
Alcon management to meet virtually with BTIG » 11:54
06/12/20
06/12
11:54
06/12/20
11:54
ALC

Alcon

$57.85 /

-0.13 (-0.22%)

Virtual Meeting to be…

Virtual Meeting to be held on June 15 hosted by BTIG.

ShowHide Related Items >><<
ALC Alcon
$57.85 /

-0.13 (-0.22%)

ALC Alcon
$57.85 /

-0.13 (-0.22%)

06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/21/20 JPMorgan
Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan
05/14/20 UBS
Alcon price target raised to CHF 65 from CHF 60 at UBS
05/14/20 Stephens
Alcon upgraded to Overweight on quicker bounce back potential at Stephens
ALC Alcon
$57.85 /

-0.13 (-0.22%)

Conference/Events
Goldman Sachs to hold a virtual conference » 04:55
06/11/20
06/11
04:55
06/11/20
04:55
CERN

Cerner

$71.85 /

-0.03 (-0.04%)

, INCY

Incyte

$93.07 /

+ (+0.00%)

, ALC

Alcon

$61.28 /

-0.22 (-0.36%)

, MDT

Medtronic

$97.57 /

-1.44 (-1.45%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, FMS

Fresenius Medical

$43.62 /

+0.18 (+0.41%)

, IVBXF

Innovent Biologics

$0.00 /

+ (+0.00%)

, QURE

uniQure

$63.09 /

-0.08 (-0.13%)

, SWTX

SpringsWorks Therapeutics

$45.20 /

+2.21 (+5.14%)

41st Annual Global…

41st Annual Global Healthcare Virtual Conference will be held on June 9-11. Webcast Link

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$45.20 /

+2.21 (+5.14%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QURE uniQure
$63.09 /

-0.08 (-0.13%)

MDT Medtronic
$97.57 /

-1.44 (-1.45%)

INCY Incyte
$93.07 /

+ (+0.00%)

FMS Fresenius Medical
$43.62 /

+0.18 (+0.41%)

CERN Cerner
$71.85 /

-0.03 (-0.04%)

ALC Alcon
$61.28 /

-0.22 (-0.36%)

CERN Cerner
$71.85 /

-0.03 (-0.04%)

06/10/20 Lake Street
OptimizeRx news strategically significant, broadens reach, says Lake Street
06/09/20 Piper Sandler
GAO reports validate Cerner contract with VA, says Piper Sandler
05/01/20 SunTrust
Cerner downgraded to Hold from Buy at SunTrust
05/01/20 SunTrust
Cerner downgraded to Hold from Buy at SunTrust
INCY Incyte
$93.07 /

+ (+0.00%)

06/04/20 Argus
Incyte price target raised to $124 from $92 at Argus
05/26/20 Goldman Sachs
Incyte downgraded to Buy from Conviction Buy at Goldman Sachs
05/19/20 Cantor Fitzgerald
Incyte price target raised to $100 from $83 at Cantor Fitzgerald
05/06/20 Piper Sandler
Incyte approval of Tabrecta came soon than expected, says Piper Sandler
ALC Alcon
$61.28 /

-0.22 (-0.36%)

06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/21/20 JPMorgan
Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan
05/14/20 UBS
Alcon price target raised to CHF 65 from CHF 60 at UBS
05/14/20 Stephens
Alcon upgraded to Overweight on quicker bounce back potential at Stephens
MDT Medtronic
$97.57 /

-1.44 (-1.45%)

05/26/20 SunTrust
Medtronic price target lowered to $105 from $130 at SunTrust
05/21/20 Piper Sandler
Medtronic price target lowered to $120 from $135 at Piper Sandler
05/21/20 Piper Sandler
Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler
05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
RHHBY Roche
$0.00 /

+ (+0.00%)

06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
06/10/20 Morgan Stanley
Morgan Stanley calls Merck bladder cancer failure 'marginal perception negative'
05/15/20 Barclays
Roche price target raised to CHF 395 from CHF 385 at Barclays
05/14/20 Mizuho
Arcus Biosciences price target raised to $40 from $22 at Mizuho
FMS Fresenius Medical
$43.62 /

+0.18 (+0.41%)

06/01/20 Barclays
Fresenius Medical price target raised to EUR 88 from EUR 81 at Barclays
05/20/20
Fly Intel: Top five analyst upgrades
05/20/20 Morgan Stanley
Fresenius Medical upgraded to Equal Weight from Underweight at Morgan Stanley
05/19/20 JPMorgan
Fresenius Medical price target lowered to EUR 84.20 from EUR 90.80 at JPMorgan
IVBXF Innovent Biologics
$0.00 /

+ (+0.00%)

QURE uniQure
$63.09 /

-0.08 (-0.13%)

03/26/20 Piper Sandler
uniQure trial delay 'comes as no surprise,' says Piper Sandler
01/23/20 Cantor Fitzgerald
Cantor sees further upside in uniQure, calls 'highly attractive' buyout candiate
12/10/19 Mizuho
uniQure price target raised to $90 from $67 at Mizuho
12/09/19 Piper Sandler
Piper says uniQure solidified 'front runner' position in Hemophilia B at ASH
SWTX SpringsWorks Therapeutics
$45.20 /

+2.21 (+5.14%)

06/02/20 Citi
Ayala Pharmaceuticals initiated with a Buy at Citi
05/05/20 Barclays
SpringsWorks Therapeutics initiated with an Overweight at Barclays
03/19/20 H.C. Wainwright
SpringsWorks Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
03/04/20
Fly Intel: Top five analyst downgrades
SWTX SpringsWorks Therapeutics
$45.20 /

+2.21 (+5.14%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QURE uniQure
$63.09 /

-0.08 (-0.13%)

MDT Medtronic
$97.57 /

-1.44 (-1.45%)

INCY Incyte
$93.07 /

+ (+0.00%)

FMS Fresenius Medical
$43.62 /

+0.18 (+0.41%)

CERN Cerner
$71.85 /

-0.03 (-0.04%)

ALC Alcon
$61.28 /

-0.22 (-0.36%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MDT Medtronic
$97.57 /

-1.44 (-1.45%)

CERN Cerner
$71.85 /

-0.03 (-0.04%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QURE uniQure
$63.09 /

-0.08 (-0.13%)

MDT Medtronic
$97.57 /

-1.44 (-1.45%)

INCY Incyte
$93.07 /

+ (+0.00%)

CERN Cerner
$71.85 /

-0.03 (-0.04%)

QURE uniQure
$63.09 /

-0.08 (-0.13%)

MDT Medtronic
$97.57 /

-1.44 (-1.45%)

INCY Incyte
$93.07 /

+ (+0.00%)

CERN Cerner
$71.85 /

-0.03 (-0.04%)

Conference/Events
Goldman Sachs to hold a virtual conference » 04:55
06/10/20
06/10
04:55
06/10/20
04:55
CERN

Cerner

$71.88 /

-1.95 (-2.64%)

, INCY

Incyte

$93.27 /

-1.3 (-1.37%)

, ALC

Alcon

$61.50 /

-1.465 (-2.33%)

, MDT

Medtronic

$99.01 /

-2.17 (-2.14%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, FMS

Fresenius Medical

$43.44 /

-0.25 (-0.57%)

, IVBXF

Innovent Biologics

$0.00 /

+ (+0.00%)

, QURE

uniQure

$63.17 /

+1.67 (+2.72%)

, SWTX

SpringsWorks Therapeutics

$42.99 /

+3.83 (+9.78%)

41st Annual Global…

41st Annual Global Healthcare Virtual Conference will be held on June 9-11. Webcast Link

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$42.99 /

+3.83 (+9.78%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QURE uniQure
$63.17 /

+1.67 (+2.72%)

MDT Medtronic
$99.01 /

-2.17 (-2.14%)

INCY Incyte
$93.27 /

-1.3 (-1.37%)

FMS Fresenius Medical
$43.44 /

-0.25 (-0.57%)

CERN Cerner
$71.88 /

-1.95 (-2.64%)

ALC Alcon
$61.50 /

-1.465 (-2.33%)

CERN Cerner
$71.88 /

-1.95 (-2.64%)

06/09/20 Piper Sandler
GAO reports validate Cerner contract with VA, says Piper Sandler
05/01/20 SunTrust
Cerner downgraded to Hold from Buy at SunTrust
05/01/20 SunTrust
Cerner downgraded to Hold from Buy at SunTrust
04/22/20
Fly Intel: Top five analyst upgrades
INCY Incyte
$93.27 /

-1.3 (-1.37%)

06/04/20 Argus
Incyte price target raised to $124 from $92 at Argus
05/26/20 Goldman Sachs
Incyte downgraded to Buy from Conviction Buy at Goldman Sachs
05/19/20 Cantor Fitzgerald
Incyte price target raised to $100 from $83 at Cantor Fitzgerald
05/06/20 Piper Sandler
Incyte approval of Tabrecta came soon than expected, says Piper Sandler
ALC Alcon
$61.50 /

-1.465 (-2.33%)

06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/21/20 JPMorgan
Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan
05/14/20 UBS
Alcon price target raised to CHF 65 from CHF 60 at UBS
05/14/20 Stephens
Alcon upgraded to Overweight on quicker bounce back potential at Stephens
MDT Medtronic
$99.01 /

-2.17 (-2.14%)

05/26/20 SunTrust
Medtronic price target lowered to $105 from $130 at SunTrust
05/21/20 Piper Sandler
Medtronic price target lowered to $120 from $135 at Piper Sandler
05/21/20 Piper Sandler
Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler
05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
RHHBY Roche
$0.00 /

+ (+0.00%)

05/15/20 Barclays
Roche price target raised to CHF 395 from CHF 385 at Barclays
05/14/20 Mizuho
Arcus Biosciences price target raised to $40 from $22 at Mizuho
05/13/20 Wolfe Research
Roche upgraded to Outperform from Peer Perform at Wolfe Research
05/13/20 Wolfe Research
Roche upgraded to Outperform from Peer Perform at Wolfe Research
FMS Fresenius Medical
$43.44 /

-0.25 (-0.57%)

06/01/20 Barclays
Fresenius Medical price target raised to EUR 88 from EUR 81 at Barclays
05/20/20
Fly Intel: Top five analyst upgrades
05/20/20 Morgan Stanley
Fresenius Medical upgraded to Equal Weight from Underweight at Morgan Stanley
05/19/20 JPMorgan
Fresenius Medical price target lowered to EUR 84.20 from EUR 90.80 at JPMorgan
IVBXF Innovent Biologics
$0.00 /

+ (+0.00%)

QURE uniQure
$63.17 /

+1.67 (+2.72%)

03/26/20 Piper Sandler
uniQure trial delay 'comes as no surprise,' says Piper Sandler
01/23/20 Cantor Fitzgerald
Cantor sees further upside in uniQure, calls 'highly attractive' buyout candiate
12/10/19 Mizuho
uniQure price target raised to $90 from $67 at Mizuho
12/09/19 Piper Sandler
Piper says uniQure solidified 'front runner' position in Hemophilia B at ASH
SWTX SpringsWorks Therapeutics
$42.99 /

+3.83 (+9.78%)

06/02/20 Citi
Ayala Pharmaceuticals initiated with a Buy at Citi
05/05/20 Barclays
SpringsWorks Therapeutics initiated with an Overweight at Barclays
03/19/20 H.C. Wainwright
SpringsWorks Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
03/04/20
Fly Intel: Top five analyst downgrades
SWTX SpringsWorks Therapeutics
$42.99 /

+3.83 (+9.78%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QURE uniQure
$63.17 /

+1.67 (+2.72%)

MDT Medtronic
$99.01 /

-2.17 (-2.14%)

INCY Incyte
$93.27 /

-1.3 (-1.37%)

FMS Fresenius Medical
$43.44 /

-0.25 (-0.57%)

CERN Cerner
$71.88 /

-1.95 (-2.64%)

ALC Alcon
$61.50 /

-1.465 (-2.33%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MDT Medtronic
$99.01 /

-2.17 (-2.14%)

CERN Cerner
$71.88 /

-1.95 (-2.64%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QURE uniQure
$63.17 /

+1.67 (+2.72%)

MDT Medtronic
$99.01 /

-2.17 (-2.14%)

INCY Incyte
$93.27 /

-1.3 (-1.37%)

CERN Cerner
$71.88 /

-1.95 (-2.64%)

QURE uniQure
$63.17 /

+1.67 (+2.72%)

MDT Medtronic
$99.01 /

-2.17 (-2.14%)

INCY Incyte
$93.27 /

-1.3 (-1.37%)

CERN Cerner
$71.88 /

-1.95 (-2.64%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.